eNauka - pregled
Pregled prema Projekat AstraZeneca Pharmaceuticals LP
Prikaz rezultata 1 do 4 od 4
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2019 | Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial | Hochman, Judith S; ...; Beleslin, Branko D   ; Cemerlic-Adjic, Nada B; ...; Stankovic, Goran R ; Apostolovic, Svetlana R ; ...; (broj, koautora 433) | Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
| 2023 | Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial | Borlaug, Barry A; Reddy, Yogesh NV; Braun, Amanda; Sorimachi, Hidemi; Omar, Massar; Popovic, Dejana R; Alogna, Alessio; Jensen, Michael D; Carter, Rickey | Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ |
| 2025 | Defining patient-reported outcomes in diabetes, obesity, cardiovascular disease, and chronic kidney disease for clinical practice guidelines - perspectives of the taskforce of the Guideline Workshop | Barnard, Kelly Katharine; ...; Lalic, Nebojsa M; ...; (broj, koautora 26) | Naučni članak | 21aM21a - Vodeći međunarodni časopis kategorije M21a |
| 2024 | Disparities in prevalence and treatment of diabetes, cardiovascular and chronic kidney diseases - Recommendations from the taskforce of the guideline workshop | Gavin, James R; ...; Lalic, Nebojsa M; ...; (broj, koautora 22) | Naučni članak | 21aM21a - Vodeći međunarodni časopis kategorije M21a |